Indiana University Research and Technology Corporation
Mark S. Long announced today he will be stepping down as president and chief executive officer of the Indiana University Research and Technology Corp. on March 30. Long will remain a special adviser and consultant to IU Vice President for Engagement Bill Stephan through the remainder of the year. Stephan is expected to head IURTC on an interim basis while the university seeks Long's successor.
Full Story >>
The Indiana University Research and Technology Corp. has agreed to license iOffice 2.0 to University of Cincinnati International Services. iOffice is software that helps academies manage international student and scholar data. The program package was developed by Jason Baumgartner in IU's Office of International Services.
Full Story >>
SpheroSense Technologies Inc. has entered into a licensing agreement with the Indiana University Research & Technology Corp. to develop market-ready biosensor technologies. SpheroSense has chosen a headquarters for its research and development activities on Bloomington's south side.
Full Story >>
Indiana University faculty and staff filed a record 116 patent applications in fiscal year 2007. The increase is likely the result of stepped-up university efforts to encourage its researchers to develop their academic work with an eye for the market. The IU Research & Technology Corporation, which keeps track of university technology transfer and development activities, also received 216 invention disclosures, executed 70 licenses and options and helped form five new businesses in FY '07 (through its Emerging Technologies Center), also a record.
Full Story >>
Navigating complex U.S. Food and Drug Administration regulations can be vexing for a young or understaffed pharmaceutical or medical device company. So it's fortunate Indiana life sciences companies can rely on locally owned Safis Solutions, LLC, for help.
Full Story >>
A team of medical professionals at the Midwest Proton Radiotherapy Institute (MPRI) and Indiana University Cyclotron Facility (IUCF) have treated the first patient in the world using an industrial robotic patient positioning system with a rotating gantry. "Proton therapy has long been regarded (50 years) as the preeminent form of delivery of irradiation for tumors, both benign and malignant," said MPRI Medical Director Allan Thornton, M.D. "However, the traditional delivery methods have been laborious, allowing only a handful of patients per day to be treated with the 1mm exactitude, taking advantage of the significant savings from proton radiation to 'normal', non-targeted tissue."
Full Story >>
